Marcel Buttner
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Clinical and treatment-related predictors of complete response after total neoadjuvant therapy for rectal cancer in a large multicenter analysis.
Journal: Clinical and translational radiation oncology
Published: December 29, 2025
Leveraging large language models to populate structured clinical case report forms from unstructured medical notes in radiation oncology.
Journal: Clinical and translational radiation oncology
Published: December 02, 2025
Oxaliplatin-induced neuropathy after total neoadjuvant therapy for rectal cancer: Dose-response relationship and impact on quality of life.
Journal: International journal of cancer
Published: November 10, 2025
Short-course radiotherapy versus long-course chemoradiotherapy in total neoadjuvant therapy of rectal cancer - A multicenter analysis of early outcomes and toxicity.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: July 16, 2025
Rectal stenosis after immunotherapy in a mismatch repair deficient rectal cancer. Case report and review of literature.
Journal: Clinical and translational radiation oncology
Published: March 07, 2025
Simultaneous integrated boost to lateral pelvic lymph nodes during chemoradiotherapy in high-risk rectal cancer.
Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Published: August 09, 2024
Tumor board simulation improves interdisciplinary decision-making in medical students.
Journal: Journal of cancer research and clinical oncology
Published: June 15, 2024
FET PET-based target volume delineation for the radiotherapy of glioblastoma: A pictorial guide to help overcome methodological pitfalls.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: April 15, 2024
Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06).
Journal: Clinical and translational radiation oncology
Published: March 12, 2024
Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12).
Journal: Clinical and translational radiation oncology
Published: July 26, 2023
Principles of oncology taught in a one-week course.
Journal: Journal of cancer research and clinical oncology
Published: July 20, 2023
Current situation in radiation oncology residency-Results of a national survey performed by the working group Young DEGRO of the German Society of Radiation Oncology.
Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Published: June 08, 2023
Last Updated: 09/26/2026